Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. This clinical trial will test if …

Coronary Artery Disease Risk Factors MultipleCoronary Artery Disease ProgressionPrevention & Control+1 more

~Estimated

~$10 – $6,250

Duke UniversityNCT07232069

Phase 2

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus

Background: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart…

Systemic Lupus ErythematosusCardiovascular DiseasePremature Atherosclerosis

~Estimated

~$10 – $5,625

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT05440422